Notice Concerning Differences Between Forecast and Actual Results for the Second Quarter of FY2026 (Interim Period) and Revision of Full-Year Earnings11/14TDnetPDF(208KB)
Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)11/14TDnetPDF(458KB)
Notice Concerning the Determination of Allotment of Stock Acquisition Rights as Stock-Based Compensation-Type Stock Options to Directors 9/16TDnetPDF(146KB)
Notice Concerning the Allotment of Stock Acquisition Rights as Stock-Based Compensation-Type Stock Options to Directors8/19TDnetPDF(460KB)
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP)8/8TDnetPDF(406KB)
Notice Concerning Determination of Terms for the Issuance of Stock Acquisition Rights as Stock Options6/13TDnetPDF(147KB)
Notice Regarding Determination of Terms and Conditions for Issuance of Stock Acquisition Rights as Stock Options 6/6TDnetPDF(106KB)
Notice Concerning Completion of Transfer of “XEBIO Arena Sendai” to Sendai City and Finalization of Extraordinary Loss6/2TDnetPDF(115KB)
[Summary]Consolidated Financial Results for the Fiscal Year Ended March 31,2025(Under Japanese GAAP)5/9TDnetPDF(514KB)
Extraordinary Losses Related to Business Structural Reform in FY2024 Consolidated financial Results, and Revision of Earnings and Dividend Forecast4/28TDnetPDF(138KB)